Great West Life Assurance CO Protagonist Therapeutics, Inc Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 56,536 shares of PTGX stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,536
Previous 5,213
984.52%
Holding current value
$2.35 Million
Previous $181,000
1304.97%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PTGX
# of Institutions
247Shares Held
56.4MCall Options Held
76.3KPut Options Held
114K-
Farallon Capital Management LLC San Francisco, CA5.86MShares$244 Million1.32% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$240 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$226 Million3.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$176 Million0.0% of portfolio
-
State Street Corp Boston, MA3.18MShares$133 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.04B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...